Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 159

1.

Psychiatrists' awareness of adherence to antipsychotic medication in patients with schizophrenia: results from a survey conducted across Europe, the Middle East, and Africa.

Olivares JM, Alptekin K, Azorin JM, Cañas F, Dubois V, Emsley R, Gorwood P, Haddad PM, Naber D, Papageorgiou G, Roca M, Thomas P, Martinez G, Schreiner A.

Patient Prefer Adherence. 2013;7:121-32. doi: 10.2147/PPA.S37534. Epub 2013 Jan 30.

2.

Psychiatrists' awareness of partial and nonadherence to antipsychotic medication in schizophrenia: results from an Asia-Pacific survey.

Olivares JM, Thirunavukarasu M, Kulkarni J, Zhang HY, Zhang M, Zhang F.

Neuropsychiatr Dis Treat. 2013;9:1163-70. doi: 10.2147/NDT.S49080. Epub 2013 Aug 12.

3.

Psychiatrists' perceptions of potential reasons for non- and partial adherence to medication: results of a survey in bipolar disorder from eight European countries.

Vieta E, Azorin JM, Bauer M, Frangou S, Perugi G, Martinez G, Schreiner A.

J Affect Disord. 2012 Dec 20;143(1-3):125-30. doi: 10.1016/j.jad.2012.05.041. Epub 2012 Jul 25.

PMID:
22840608
4.

Psychiatrists' awareness of partial- and non-adherence to antipsychotic medication in schizophrenia: results from the Australian ADHES survey.

Kulkarni J, Reeve-Parker K.

Australas Psychiatry. 2015 Jun;23(3):258-64. doi: 10.1177/1039856215576396. Epub 2015 Mar 17.

PMID:
25783668
5.

Schizophrenia through the carers' eyes: results of a European cross-sectional survey.

Svettini A, Johnson B, Magro C, Saunders J, Jones K, Silk S, Hargarter L, Schreiner A.

J Psychiatr Ment Health Nurs. 2015 Sep;22(7):472-83. doi: 10.1111/jpm.12209. Epub 2015 May 6.

PMID:
25944551
6.

Survey of medication adherence in patients with schizophrenia--Korean ADHES data.

Kim SW, Yoon JS, Choi SK.

Hum Psychopharmacol. 2006 Dec;21(8):533-7.

PMID:
17133616
7.

Nurses' perceptions of medication adherence in schizophrenia: results of the ADHES cross-sectional questionnaire survey.

Emsley R, Alptekin K, Azorin JM, Cañas F, Dubois V, Gorwood P, Haddad PM, Naber D, Olivares JM, Papageorgiou G, Roca M, Thomas P, Hargarter L, Schreiner A; EMEA ADHES group.

Ther Adv Psychopharmacol. 2015 Dec;5(6):339-50. doi: 10.1177/2045125315612013.

8.

The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness.

Velligan DI, Weiden PJ, Sajatovic M, Scott J, Carpenter D, Ross R, Docherty JP; Expert Consensus Panel on Adherence Problems in Serious and Persistent Mental Illness.

J Clin Psychiatry. 2009;70 Suppl 4:1-46; quiz 47-8. Review.

9.

Substance abuse and the management of medication nonadherence in schizophrenia.

Wilk J, Marcus SC, West J, Countis L, Hall R, Regier DA, Olfson M.

J Nerv Ment Dis. 2006 Jun;194(6):454-7.

PMID:
16772865
10.

A pilot study of barriers to medication adherence in schizophrenia.

Hudson TJ, Owen RR, Thrush CR, Han X, Pyne JM, Thapa P, Sullivan G.

J Clin Psychiatry. 2004 Feb;65(2):211-6.

PMID:
15003075
11.

A prospective study of risk factors for nonadherence with antipsychotic medication in the treatment of schizophrenia.

Ascher-Svanum H, Zhu B, Faries D, Lacro JP, Dolder CR.

J Clin Psychiatry. 2006 Jul;67(7):1114-23.

PMID:
16889456
12.

Psychiatrist and patient responses to suspected medication nonadherence in schizophrenia spectrum disorders.

Hamann J, Lipp ML, Christ-Zapp S, Spellmann I, Kissling W.

Psychiatr Serv. 2014 Jul;65(7):881-7. doi: 10.1176/appi.ps.201300322.

PMID:
24686753
13.
14.

Partial compliance with antipsychotic medication is common in patients with schizophrenia.

Rummel-Kluge C, Schuster T, Peters S, Kissling W.

Aust N Z J Psychiatry. 2008 May;42(5):382-8. doi: 10.1080/00048670801961107.

PMID:
18473256
15.

Psychiatrists' attitudes to maintenance medication for patients with schizophrenia.

Patel MX, Nikolaou V, David AS.

Psychol Med. 2003 Jan;33(1):83-9.

PMID:
12537039
16.

Importance of open access to atypical antipsychotics for the treatment of schizophrenia and bipolar disorder: a European perspective.

Altamura AC, Armadoros D, Jaeger M, Kernish R, Locklear J, Volz HP.

Curr Med Res Opin. 2008 Aug;24(8):2271-82. doi: 10.1185/03007990802250056. Epub 2008 Jun 26.

PMID:
18588748
17.

Improving adherence to antipsychotic pharmacotherapy.

Masand PS, Narasimhan M.

Curr Clin Pharmacol. 2006 Jan;1(1):47-56. Review.

PMID:
18666377
18.

Psychiatrists' perceptions of the clinical importance, assessment and management of patient functioning in schizophrenia in Europe, the Middle East and Africa.

Gorwood P, Burns T, Juckel G, Rossi A, San L, Hargarter L, Schreiner A; Europe, Middle East and Africa functioning group.

Ann Gen Psychiatry. 2013 Mar 26;12(1):8. doi: 10.1186/1744-859X-12-8.

19.

Awareness of illness and nonadherence to antipsychotic medications among persons with schizophrenia.

Olfson M, Marcus SC, Wilk J, West JC.

Psychiatr Serv. 2006 Feb;57(2):205-11.

PMID:
16452697
20.

[Relationships between insight and medication adherence in subjects with psychosis].

Droulout T, Liraud F, Verdoux H.

Encephale. 2003 Sep-Oct;29(5):430-7. French.

PMID:
14615692

Supplemental Content

Support Center